Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study for Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease

NCT01108978 is registered in ClinicalTrials.gov with Nang Kuang Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01108978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01108978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study for Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease
Lead sponsor
Nang Kuang Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2010
Completion date
May 31, 2011
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, hypercholesterolemia, type 2 diabetes mellitus